Science In (UK) Top Management
SIS Stock | 27.00 0.50 1.89% |
Science In employs about 330 people. The company is managed by 9 executives with a total tenure of roughly 770 years, averaging almost 85.0 years of service per executive, having 36.67 employees per reported executive. Evaluation of Science In's management performance can provide insight into the firm performance.
Stephen Moon CEO CEO Director |
Daniel Wright Chairman Executive Chairman |
Science |
Science In Management Team Effectiveness
The company has return on total asset (ROA) of (0.0801) % which means that it has lost $0.0801 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3289) %, meaning that it generated substantial loss on money invested by shareholders. Science In's management efficiency ratios could be used to measure how well Science In manages its routine affairs as well as how well it operates its assets and liabilities. At present, Science In's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 13 M, whereas Other Current Assets are forecasted to decline to about 2.1 M.The current year's Common Stock Shares Outstanding is expected to grow to about 178.6 M, whereas Net Loss is projected to grow to (9.3 M).
Science In Workforce Comparison
Science in Sport is currently regarded as top stock in number of employees category among its peers. The total workforce of Consumer Staples industry is at this time estimated at about 102,285. Science In adds roughly 330 in number of employees claiming only tiny portion of stocks in Consumer Staples industry.
The company has Profit Margin (PM) of (0.19) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07. Science in Sport Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Science in Sport Price Series Summation is a cross summation of Science In price series and its benchmark/peer.
Science In Notable Stakeholders
A Science In stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Science In often face trade-offs trying to please all of them. Science In's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Science In's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Stephen Moon | CEO Director | Profile | |
Daniel Wright | Executive Chairman | Profile | |
Christopher Welsh | CFO Director | Profile | |
Daniel Lampard | Chief Director | Profile | |
Stephen MBA | Executive Director | Profile | |
Bernadette UdeWetherell | Chief Officer | Profile | |
Megan Blaylock | Chief Officer | Profile | |
Muna Khan | Chief Officer | Profile | |
Andy Bott | Chief Officer | Profile |
About Science In Management Performance
The success or failure of an entity such as Science in Sport often depends on how effective the management is. Science In management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Science management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Science management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Science In is entity of United Kingdom. It is traded as Stock on LSE exchange.
Please note, the presentation of Science In's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Science In's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Science In's management manipulating its earnings.
Science In Workforce Analysis
Traditionally, organizations such as Science In use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Science In within its industry.Science In Manpower Efficiency
Return on Science In Manpower
Revenue Per Employee | 189.9K | |
Revenue Per Executive | 7M | |
Net Loss Per Employee | 34.2K | |
Net Loss Per Executive | 1.3M |
Complementary Tools for Science Stock analysis
When running Science In's price analysis, check to measure Science In's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Science In is operating at the current time. Most of Science In's value examination focuses on studying past and present price action to predict the probability of Science In's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Science In's price. Additionally, you may evaluate how the addition of Science In to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |